Research_医药人-Daniel:http://t.cn/Ev61ROJ。-- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced that it has entered into a Master Clinical Supply Agreement (Agreeme